.jpg)
Navin Fluorine International Limited (NFIL) achieved a milestone with the launch of Phase-1 of its new cGMP-4 plant at the Navin Molecular location within its Dewas unit. The launch, in front of its distinguished European pa...
Botanic Healthcare, an international leader in natural ingredients, nutraceutical development, has launched its cutting-edge Liposomal Manufacturing Facility in Hyderabad, India, representing a major advancement in enhanced delivery technologies...
Artificial intelligence (AI) is being seen by the Indian healthcare industry as a strategic necessity that will enable next-generation treatments and increase systemic efficiency throughout the industry
Tata Elxsi, a global leader in design and technology services, announced the inauguration of the ‘Bayer Development Centre in Radiology’ at Tata Elxsi, Pune, India
Emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA), has been given Fast Track designation by the U.S. Food and Drug Administration (FDA), according to a statement released today by Teva Pharmaceuticals
Today Eli Lilly and Company announced Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that enables biotech firms to access sophisticated models for drug discovery based on decades of Lilly data...
Eli Lilly's (LLY.N), opens new tab approved blood cancer therapy Jaypirca has demonstrated its ability to delay disease progression in patients who had not received prior treatment, as evidenced by a late-stage study, positioning it as a potential
Alcon, a prominent leader in eye care committed to enhancing vision, has recently unveiled the UNITY Vitreoretinal Cataract System (VCS) and the UNITY Cataract System (CS) in India.
Sanjivani Paranteral Limited's subsidiary, SPL Infusion Pvt. Ltd., has initiated commercial production at its newly established IV Fluid Infusion Plant located in Pune, Maharashtra, effective from 6th September 2025, following the acquisition of the
Cipla has officially launched HUENA (Methenamine Hippurate), India's first non-antibiotic UTI drug. This is especially timely, as UTIs are the second most common reason for antibiotic use in India, with the number of cases nearly doubling over the...
.jpg)
, CDSCO.jpg)